Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice—a prospective single-center trial

PURPOSE: Knowledge on Ruxolitinib exposure in patients with graft versus host disease (GvHD) is scarce. The purpose of this prospective study was to analyze Ruxolitinib concentrations of GvHD patients and to investigate effects of CYP3A4 and CYP2C9 inhibitors and other covariates as well as concentr...

Descripción completa

Detalles Bibliográficos
Autores principales: Isberner, Nora, Kraus, Sabrina, Grigoleit, Götz Ulrich, Aghai, Fatemeh, Kurlbaum, Max, Zimmermann, Sebastian, Klinker, Hartwig, Scherf-Clavel, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536600/
https://www.ncbi.nlm.nih.gov/pubmed/34505930
http://dx.doi.org/10.1007/s00280-021-04351-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536600/
https://www.ncbi.nlm.nih.gov/pubmed/34505930
http://dx.doi.org/10.1007/s00280-021-04351-w

Ejemplares similares